(Q57594274)

https://api.crossref.org/works/10.1517%2F14712590802494501

Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

TCR antagonism and T cell tolerance can be independently induced in a DR-restricted, hemagglutinin-specific T cell clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Antagonism of superantigen-stimulated helper T-cell clones and hybridomas by altered peptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

A functional hot spot for antigen recognition in a superagonist TCR/MHC complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

A structural difference limited to one residue of the antigenic peptide can profoundly alter the biological outcome of the TCR-peptide/MHC class I interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Strain differences in the autoimmune response of mice to acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

The role of T cells in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Analysis of TCR antagonism and molecular mimicry of an HLA-A0201-restricted CTL epitope in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Type II collagen is a target antigen of clonally expanded T cells in the synovium of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

An altered peptide ligand of type II collagen suppresses autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Identification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39(263-275) epitope: an MHC anchor variant peptide for immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Insulin as an autoantigen in NOD/human diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Imogen 38: a novel 38-kD islet mitochondrial autoantigen recognized by T cells from a newly diagnosed type 1 diabetic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Modulation of T cell response to hGAD65 peptide epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Potential of an altered peptide ligand of lipocalin allergen Bos d 2 for peptide immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Towards immunotherapeutic drugs and vaccines against multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Selection of encephalitogenic rat T-lymphocyte clones recognizing an immunodominant epitope on myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72-85.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Design and synthesis of a novel potent myelin basic protein epitope 87-99 cyclic analogue: enhanced stability and biological properties of mimics render them a potentially new class of immunomodulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Round and round we go: cyclic peptides in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Antagonistic Effects of Human Cyclic MBP87-99Altered Peptide Ligands in Experimental Allergic Encephalomyelitis and Human T-Cell Proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Treatment of experimental allergic encephalomyelitis (EAE) induced by guinea pig myelin basic protein epitope 72-85 with a human MBP(87-99) analogue and effects of cyclic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

A double mutation of MBP83–99 peptide induces IL-4 responses and antagonizes IFN-γ responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Synthesis and study of the electrophoretic behavior of mannan conjugates with cyclic peptide analogue of myelin basic protein using lysine-glycine linker

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Role of the mannose receptor in the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Cell-mediated immune responses to MUC1 fusion protein coupled to mannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Crystal structure of a non-canonical low-affinity peptide complexed with MHC class I: a new approach for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Mannosylation of mutated MBP83-99 peptides diverts immune responses from Th1 to Th2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

The in vivo expansion rate of properly stimulated transferred CD8+ T cells exceeds that of an aggressively growing mouse tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

MUC1 peptide epitopes associated with five different H-2 class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Noncanonical peptides in complex with MHC class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Getting into the groove: unusual features of peptide binding to MHC class I molecules and implications in vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

MHC and MHC-like molecules: structural perspectives on the design of molecular vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Insights into peptide-based vaccine design for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Rational Peptide-based vaccine design for cancer immunotherapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Enhanced expression of lymphotactin by CD8+ T cells is selectively induced by enhancer agonist peptides of tumor-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

An altered peptide ligand for naïve cytotoxic T lymphocyte epitope of TRP-2(180-188) enhanced immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Substitution analog peptide derived from HER-2 can efficiently induce HER-2-specific, HLA-A24 restricted CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu-expressing tumor cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4(+) cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Human T-cell recognition of the circumsporozoite protein of plasmodium falciparum: Immunodominant T-cell domains map to the polymorphic regions of the molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

The immunology of malaria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Naturally exposed populations differ in their T1 and T2 responses to the circumsporozoite protein of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

The epidemiology of multiple-clone Plasmodium falciparum infections in Gambian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Association of malaria parasite population structure, HLA, and immunological antagonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Identification of a novel peptide derived from the melanocyte-specific gp100 antigen as the dominant epitope recognized by an HLA-A2.1-restricted anti-melanoma CTL line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501

Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590802494501